Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP494881.RAIKt-GwpfH_HA50KMIKOTuS8Impj4y0QAd3gztYL2fzo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP494881.RAIKt-GwpfH_HA50KMIKOTuS8Impj4y0QAd3gztYL2fzo130_assertion type Assertion NP494881.RAIKt-GwpfH_HA50KMIKOTuS8Impj4y0QAd3gztYL2fzo130_head.
- NP494881.RAIKt-GwpfH_HA50KMIKOTuS8Impj4y0QAd3gztYL2fzo130_assertion description "[In NHLs, WT1 was positive in 4 of 5 (80%) Burkitt lymphomas, 9 of 12 (75%) ALK-positive ALCLs, 3 of 6 (50%) lymphoblastic lymphomas (2 of 4 T-cell, 1 of 2 B-cell), 14 of 31 (45%) ALK-negative ALCLs, 6 of 18 (33%) DLBCLs, and 1 of 6 (17%) cutaneous ALCLs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP494881.RAIKt-GwpfH_HA50KMIKOTuS8Impj4y0QAd3gztYL2fzo130_provenance.
- NP494881.RAIKt-GwpfH_HA50KMIKOTuS8Impj4y0QAd3gztYL2fzo130_assertion evidence source_evidence_literature NP494881.RAIKt-GwpfH_HA50KMIKOTuS8Impj4y0QAd3gztYL2fzo130_provenance.
- NP494881.RAIKt-GwpfH_HA50KMIKOTuS8Impj4y0QAd3gztYL2fzo130_assertion SIO_000772 15894924 NP494881.RAIKt-GwpfH_HA50KMIKOTuS8Impj4y0QAd3gztYL2fzo130_provenance.
- NP494881.RAIKt-GwpfH_HA50KMIKOTuS8Impj4y0QAd3gztYL2fzo130_assertion wasDerivedFrom befree-2016 NP494881.RAIKt-GwpfH_HA50KMIKOTuS8Impj4y0QAd3gztYL2fzo130_provenance.
- NP494881.RAIKt-GwpfH_HA50KMIKOTuS8Impj4y0QAd3gztYL2fzo130_assertion wasGeneratedBy ECO_0000203 NP494881.RAIKt-GwpfH_HA50KMIKOTuS8Impj4y0QAd3gztYL2fzo130_provenance.